Can PET-CT predict ovarian cancer surgery success?
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial uses PET-CT scans to create a model that predicts how completely advanced ovarian cancer can be removed during surgery. It may help doctors plan the best treatment for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have epithelial ovarian cancer (the most common type).
- You need to have had your first major surgery to remove the cancer at the hospital running this trial.
- Your cancer must be at stage IIB or higher after surgery.
- Your medical records (clinic, surgery, and lab results) should be mostly complete.
- You must not have had fertility-sparing or surgery that only eases symptoms.
- You must not have an infection at the time of your PET-CT scan.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses two types of PET/CT scans (68Ga-FAPI-46 and 18F-FDG) to look for any returning ovarian cancer. The goal is to find recurrence early so you and your doctor can plan the next steps.
This study uses advanced computer analysis of CT scans to help doctors plan the best treatment for advanced ovarian cancer. It is designed for patients who are about to start active treatment, such as surgery or chemotherapy.
This study looks at women with advanced ovarian cancer to see if certain factors can predict the type of cancer and how well surgery will work. It may help doctors plan the best treatment for you.
This trial tests a computer program (artificial intelligence) that looks at CT scans of the pelvis to help find ovarian cancer. If it works, it could help doctors diagnose this cancer earlier and more accurately.
This study tests a special imaging agent (89Zr-DFO-Mirvetuximab) that may help doctors see ovarian cancer more clearly on PET/CT scans. It is for people with advanced or recurring ovarian cancer to assess if the drug is safe and effective for imaging.
This study tests a new type of PET scan (a special imaging test) called 18F-FGIn to help doctors better detect and evaluate cancers. It may be more accurate than the standard PET scan for certain tumors like brain, liver, stomach, and colon cancers.
Hear when a new Ovarian cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.